THE PROGNOSIS AND TREATMENT OF ENDOMETRIAL CANCER

Four hundred and eighteen patients with endometrial cancer who were treated in Cancer Institute (Hospital), CAMS from 1958 to 1981 were studied retrospec-tively. 228 patients had stage Ⅰ, 105 patients had stage Ⅱ, 76 patients had stage Ⅲ,9 patients had stage Ⅵ, 75 patients had recurrent disease. In stage Ⅰ and Ⅱ,variables found to have a statistically significant influence on survival were 1).endoncervical involvement. 2). myometrical infiltration. and 3). trcatmentmodalities. Surgery and combination of surgery and radiotherapy are the optimaltreatment modolities. In stage Ⅱ false rate is 56.1%, the clinical staging mainlybased on the first fractional curettage specimen should be discussed. In stage Ⅲand Ⅵ if possible, surgical eradieation of macroscopic tumor should be performed;if inoperable, radiotherapy is the optimal method of treatment. Radiotherapyin combination with hormone therapy or chemotherapy should be stressed. Forrecurrent disease, even the treatment possibilities are limited reatment should not be abandoned. A combined treatment planning for patients with endometrialcarcinoma has also been suggested.